Its accuracy in distinguishing HCC patients from healthy controls, chronic hepatitis B patients, and cirrhosis patients (AUC values of 0.863, 0.843, and 0.864, respectively) was significantly higher than that of the traditional tumor marker AFP. This evidence concerns the gene AFP and neoplasm.